DeepMed Research

University Hospital Tuebingen

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: Private

Established: 1388-01-01

Employees: -

Market Cap: -

Website: https://www.klinikum.uni-heidelberg.de/Startseite.2.0.html?&no_cache=1

Clinical Trials

Prolactin Release Through Breast Stimulation in Non-lactating Women - Who Does Respond?

Not Applicable

Recruiting

Conditions: Breast Stimulation
Prolactin

Interventions: Other: Breast stimulation

First Posted Date: 2022-01-26

Last Posted Date: 2024-05-14

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 40

Registration Number: NCT05208684

Locations: 🇩🇪
University Hospital Tuebingen, Otfried-Mueller Str. 10, Tuebingen, Germany

Urinary Biomarkers in Paediatric Kidney Transplantation (pKTx)

Completed

Conditions: Renal Transplantation
Chronic Kidney Insufficiency
Healthy Controls

Interventions: Diagnostic Test: Biomarker test

First Posted Date: 2022-01-26

Last Posted Date: 2023-11-29

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 186

Registration Number: NCT05208788

Locations: 🇩🇪
University Children's Hospital Tuebingen, Tuebingen, Germany

Perioperative Three-dimensional Echocardiography in Cardioanesthesia.

Recruiting

Conditions: Cardiac Disease
Vascular Diseases

First Posted Date: 2022-01-13

Last Posted Date: 2022-01-13

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 2000

Registration Number: NCT05191173

Locations: 🇩🇪
Universitätsklinikum Tübingen, Tübingen, Germany

Individualized Response-adaptive Radiation Dose Prescription in HNC Based on MRI

Phase 1

Recruiting

Conditions: Head and Neck Cancer

Interventions: Radiation: Real-time ADC-guided response adaptive Boost in HNC

First Posted Date: 2021-12-16

Last Posted Date: 2022-02-01

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 24

Registration Number: NCT05160714

Locations: 🇩🇪
UKT Radiooncology, Tübingen, BW, Germany

(Bispecific) Antibodies in Cancer Patients

Conditions: Cancer

First Posted Date: 2021-11-15

Last Posted Date: 2024-05-08

Lead Sponsor: University Hospital Tuebingen

Registration Number: NCT05119257

Locations: 🇩🇪
University Hospital Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany

tVNS Effects on Motivation in Depression

Not Applicable

Completed

Conditions: Major Depressive Disorder

Interventions: Device: transcutaneous vagus nerve stimulation
Device: sham stimulation

First Posted Date: 2021-11-15

Last Posted Date: 2021-12-08

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 67

Registration Number: NCT05120336

Locations: 🇩🇪
Department of Psychiatry & Psychotherapy, University of Tübingen, Tübingen, BW, Germany

Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26)

Phase 1

Recruiting

Conditions: Leptomeningeal Disease

Interventions: Drug: Nivolumab [Opdivo]

First Posted Date: 2021-11-09

Last Posted Date: 2025-04-03

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 46

Registration Number: NCT05112549

Locations: 🇩🇪
Klinikum rechts der Isar/Technische Universität München, München, Germany
🇩🇪
University Hospital Tübingen, Neurooncology, Tübingen, Germany
🇩🇪
Universitätsklinikum Bonn, Bonn, Germany

and more 6 locations

Amiloride in Nephrotic Syndrome

Phase 3

Terminated

Conditions: Sodium Retention
Edema
Nephrotic Syndrome

Interventions: Drug: Furosemide
Drug: Amiloride

First Posted Date: 2021-10-15

Last Posted Date: 2025-01-14

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 20

Registration Number: NCT05079789

Locations: 🇩🇪
University Hospital Tuebingen, Tuebingen, Baden-Wuerttemberg, Germany

Belimumab in Patients with Chronic Lymphocytic Leukemia

Phase 2

Active, not recruiting

Conditions: Chronic Lymphoid Leukemia in Relapse

Interventions: Drug: Belimumab 200 MG/ML [Benlysta]
Drug: standard of care

First Posted Date: 2021-10-06

Last Posted Date: 2024-12-09

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 120

Registration Number: NCT05069051

Locations: 🇩🇪
University Hospital Tuebingen, CCU Translational Immunology, Tuebingen, BW, Germany

iCBT for Children and Adolescents With Obsessive-compulsive Disorder II

Not Applicable

Completed

Conditions: Psychotherapy Intervention Evaluation

Interventions: Behavioral: Cognitive-behavioral psychotherapy

First Posted Date: 2021-09-08

Last Posted Date: 2022-07-08

Lead Sponsor: University Hospital Tuebingen

Target Recruit Count: 60

Registration Number: NCT05037344

Locations: 🇩🇪
University Hospital Tuebingen, Tuebingen, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy